By Metro US
Posted on
(Reuters) – AstraZeneca’s COVID-19 vaccine was only slightly less effective against the variant first found in India than the strain identified in Kent, the company’s Chief Executive Officer Pascal Soriot said in an interview with Financial Times on Friday.
He added the company is in talks with governments, including the United Kingdom, about new contracts for booster doses.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Chris Reese)
Eagles offense sparks HUGE 4th quarter comeback win over the Commanders
Eagles vs Commanders: Philadelphia looks to dominate in Week 11 and close the gap in all-time series
Yankees radio gets new lead voice: Dave Sims taking over for legendary John Sterling behind the mic
Juan Soto rumors: Carlos Beltran says Mets going ‘full blast’ for free-agent star
Tampa Bay Rays to play 2025 home games at Yankees’ spring training facilities
LIRR from Far Rockaway to cost $2.75 during A train shutdown in Queens
Public Advocate Williams blasts Mayor Adams as becoming the ‘Trump of Brooklyn,’ questioning where his allegiance lies
Massive Manhattan gang takedown leads to 24 shooting suspects indicted, gang war stopped: DA Bragg
Police investigating missing memorial plaque for fallen officer
More MOVE bombing remains discovered at Penn MuseumEagles offense sparks HUGE 4th quarter comeback win over the Commanders
BetMGM bonus code AMNY200: Collect $200 bonus for Commanders-EaglesLIRR from Far Rockaway to cost $2.75 during A train shutdown in QueensPublic Advocate Williams blasts Mayor Adams as becoming the ‘Trump of Brooklyn,’ questioning where his allegiance lies
